ArticleCureus2026

Clinical Outcomes and Inflammatory Biomarker Changes After Intravenous Ketamine-Lidocaine Infusion in Refractory Neuropathic Pain: A Prospective Observational Pilot Study.

Ivan Keser et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.